维生素E对药物诱导的损伤的保护作用:一个元分析
Lingfei Meng1, Shengmao Liu1, Wenpeng Cui1
1Department of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin Province, China.
Frontiers in pharmacology
|April 29, 2025
概括
维生素E补充剂在治疗急性损伤 (AKI) 中表现有前途. 这篇评论发现它改善了功能标志物,并减少了AKI的发生率,提供了潜在的治疗途径.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 营养生物化学 营养生物化学
- 临床试验 临床试验
背景情况:
- 急性损伤 (AKI) 是一个重大的临床挑战,有效治疗方法有限.
- 维生素E是一种强大的抗氧化剂,已证明对脏有保护作用.
- 目前关于维生素E在AKI中的作用的临床证据稀缺且不确.
研究的目的:
- 系统地评估维生素E对急性损伤治疗的影响.
- 综合了随机对照试验中关于维生素E用于预防和治疗损伤的研究结果.
主要方法:
- 在PubMed,Embase和Cochrane图书馆数据库中进行了全面的文献搜索.
- 六个符合条件的随机对照试验被纳入了元分析.
- 用固定或随机效应模型分析了AKI发病率,血清肌素和尿素水平的数据.
主要成果:
- 补充维生素E与高估计的淋巴细胞过率 (eGFR) 水平相关.
- 在维生素E治疗后观察到血清肌素水平显著降低.
- 综合分析表明,维生素E有效抑制了AKI的发生.
结论:
- 维生素E通过增加eGFR,在改善功能方面具有有益作用.
- 维生素E治疗导致血清肌素的降低,这是损伤的关键生物标志物.
- 这一系统性审查得出结论,维生素E有效抑制急性损伤的发生.
相关概念视频
Therapeutic Index
4.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.0K
Renal Failure: Dose Adjustments
34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34
Drug Elimination by Renal Route: Tubular Reabsorption
3.0K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.0K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
991
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
991
Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
Renal Drug Excretion: Tubular Reabsorption
49
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
49


